Neuland Laboratories Limited
NEULANDLAB.NS
$-3.18
Change (1 day)
$196.55
Year High
$42.95
Year Low
Categories
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Neuland Laboratories Limited (NEULANDLAB.NS) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 44.43 M | -2,546,010 | 65.4 M | 217.97 M | 109.55 M |
| 2022 | 43.03 M | 9.88 M | 69.66 M | 187.9 M | 90.5 M |
| 2021 | 30.2 M | 28 M | 64.58 M | 164.55 M | 69.32 M |
| 2020 | 28.09 M | 21.39 M | 64.03 M | 157.57 M | 65.37 M |
| 2019 | 29.41 M | 30.04 M | 61.97 M | 146.41 M | 61.28 M |